Cargando…
Clinical significance of serum anti-granulocyte–macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis
BACKGROUND: Anti-granulocyte–macrophage colony-stimulating factor autoantibody (GMAb) has been recognized as a diagnostic biomarker for autoimmune pulmonary alveolar proteinosis (aPAP). The aims of this study were to know the incidence of increased level of serum GMAb in granulomatous lung diseases...
Autores principales: | Katayama, Kanako, Hirose, Masaki, Arai, Toru, Hatsuda, Kazuyoshi, Tachibana, Kazunobu, Sugawara, Reiko, Sugimoto, Chikatoshi, Kasai, Takahiko, Akira, Masanori, Inoue, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525969/ https://www.ncbi.nlm.nih.gov/pubmed/32993757 http://dx.doi.org/10.1186/s13023-020-01546-x |
Ejemplares similares
-
Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
por: Arai, Toru, et al.
Publicado: (2020) -
Drug-related pneumonitis with radiographic hypersensitivity pneumonitis pattern: Three case series
por: Nakamura, Yukihiro, et al.
Publicado: (2021) -
Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis
por: Tachibana, Kazunobu, et al.
Publicado: (2023) -
Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin
por: Arai, Toru, et al.
Publicado: (2021) -
B cell‐activating factors in autoimmune pulmonary alveolar proteinosis
por: Hirose, Masaki, et al.
Publicado: (2021)